Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

9 Jun 2022 07:00

RNS Number : 2258O
Sopheon PLC
09 June 2022
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, holds its Annual General Meeting ("AGM") today. The Board takes this opportunity to give shareholders the following update and review of the business.

 

2021 in review

 

Our 2021 performance was gratifying both for the strategic progress we made and for exceeding our financial market expectations despite the continued market uncertainty. Both recognized revenues and annual recurring revenues ("ARR") grew by approximately 15% to $34.4m and $20.7m respectively. We remind shareholders that we are on a journey of transition from a traditional perpetual software license business to a higher-quality recurring revenue business. The goal is to deliver more predictable and reliable growth over the medium term; in the shorter term, this transition naturally weighs on profits as we accelerate go-to-market investment while simultaneously shifting software revenue recognition from an up-front to a rateable model. It was therefore very encouraging to also show continued profitability with both EBITDA and net cash growing. In addition to our financial results, 2021 was a year of unusually high activity and change for Sopheon. We appointed a new CEO, Greg Coticchia, and also strengthened our leadership team with appointments in key marketing, sales, and product areas. We have introduced and driven three key programs to support our strategic direction to:

 

· Transition our customer base and new sales engine to Software-as-a-Service ("SaaS"). By year end, 90 percent of the new customer pipeline by value was SaaS focused.

 

· Embrace a multi-product future by introducing new cloud-based applications. These new applications are intended to drive lead generation for our Accolade enterprise solution, as well as being stand-alone solutions that solve individual and workgroup productivity needs. At year end we completed the acquisition of ROI Blueprints, which is already playing a material role in both existing and new customer opportunities.

 

· Extend market reach beyond the very largest customers and thereby improve scalability and predictability. We made significant investments in marketing which are already increasing our metrics for market reach, prospect engagement and ultimately lead generation.

 

2022 update and outlook

 

Our most recent acquisition of Solverboard, announced in May 2022, accelerates our SaaS strategy from both functional and go-to-market perspectives. Solverboard's multi-tenant, SaaS product is used by both individual innovators and product professionals, and is sold using an online, product-led model. Solverboard brings the innovation and product needs of professionals together so that they can focus on addressing front-end innovation challenges, by helping companies dynamically find, align, test and deliver the best innovation and product ideas from employees and customers. We expect to further develop Solverboard's product sales led distribution capabilities and introduce additional Sopheon products to be sold through the Solverboard channel by the end of the year.

 

In parallel with our strategic progress, we have continued delivering growth in our core business. Since the start of the year, we have closed six new customer wins - compared to ten in the whole of 2021. All six were SaaS. ARR has risen to $21.7m compared to $19m a year ago, and gross retention has held above 98% on a year-to-date basis. These metrics demonstrate continued success with our transition towards a more recurring revenue model - which in turn improves our multi-year visibility and predictability. A lower share of one-off revenue contributions from perpetual and consulting sales year to date means that full year visibility for recognizable 2022 revenue is currently at $28m, a similar level to this time last year. Confidence in our full year performance is sustained by a sales pipeline that includes several major extensions with existing customers, alongside a growing list of new prospects. Net cash at the end of May stood at $25m compared to $23m at this time last year, underlining our cash generative nature and our ability to execute.

 

Sopheon's Chairman Andy Michuda said: "Sopheon's shift towards a pure play SaaS model and associated ARR growth is moving forward as planned, supported by delivery of two key acquisitions in ROI Blueprints and most recently Solverboard. We see growing commercial traction on both sides of the Atlantic, responding to our broader product offering and our more assertive marketing investment, and we remain focused on exploring other additive M&A opportunities."

 

For further information contact:

 

Andy Michuda (Executive Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)Alice Lane/Sunila da Silva (ECM)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

Sopheon, Accolade and Solverboard are trademarks of Sopheon plc. All other trademarks are the property of their respective owners.

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSRRDITIIF
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.